Evidence map›Paper›PMID 39881860›Full record

ArticleResearch (Washington, D.C.)2025

Discovery of Novel Na

Gaoang Wang, Hang Wu, Yingying Wang, Xiangying Liu, Shuijiao Peng, Wenxing Wang, Meijing Wu, Yifei Liu, Ercheng Wang, Zhe Wang and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gaoang WangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Hang WuThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, and Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Hunan Normal University, Changsha 410081, Hunan, China.
Yingying WangZhejiang University School of Medicine, Hangzhou 310000, Zhejiang, China.
Xiangying LiuState Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Shuijiao PengThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, and Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Hunan Normal University, Changsha 410081, Hunan, China.
Wenxing WangThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, and Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Hunan Normal University, Changsha 410081, Hunan, China.
Meijing WuThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, and Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Hunan Normal University, Changsha 410081, Hunan, China.
Yifei LiuCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Ercheng WangZhejiang Laboratory, Hangzhou 311100, Zhejiang, China.
Zhe WangSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, Zhejiang, China.
Lei XuInstitute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou 213001, Jiangsu, China.
Xiaojian WangState Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Wei YangZhejiang University School of Medicine, Hangzhou 310000, Zhejiang, China.
Haiyi ChenCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Xi ZhouThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, and Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Hunan Normal University, Changsha 410081, Hunan, China.
Tingjun HouCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.ORCID https://orcid.org/0000-0001-7227-2580

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Na

Identifiers

PMID39881860
PMCPMC11775380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.